Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Oncimmune Holdings Plc LSE:ONC London Ordinary Share GB00BYQ94H38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.90 -4.47% 62.00 61.00 63.20 62.80 62.00 62.80 54,764 13:48:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -9.8 -13.4 - 43

Oncimmune Share Discussion Threads

Showing 226 to 250 of 275 messages
Chat Pages: 11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
07/3/2022
18:21
Outstanding growth expected in H2! Cheap IMHO
trotterstrading
07/3/2022
12:05
Yet another contract. They have been a bit unlucky with the market back drop against which they have been announcing this string of contract awards.
40 fathoms
06/3/2022
13:56
You probably don’t want JW to get it. Look how he got POLX …… you don’t hear him go on too much about the 100x potential on that one any more. In fact podcast suggests he has been trimming that position down.
w t tutte
06/3/2022
10:15
Brummy_git,

Thanks for that and the one 2 one earlier in the week.

It's a hidden gem, but probably due to investors not understanding the tech, or the RNS content.

Even Justin in the last interview, with his FDA comme3nt, highlights a need for the company to do a plain non tech version of the RNS and what their tech does. Maybe some PR also to attract a wider audience before it gets snapped up on the cheap!

itsyou
04/3/2022
15:44
Justin Waite & I of Vox Markets discussed Oncimmune here today (starts 49:00).

www.voxmarkets.co.uk/articles/stocks-to-follow-on-vox-markets-4th-march-2022-ef5d2a0

brummy_git
04/3/2022
15:26
Out of interest:

htTps://www.gbs-cidp.org/research/clinical-trials/current-clinical-trials/

rambutan2
04/3/2022
07:14
Another day, another contract. A NEW large pharma to boot.
40 fathoms
01/3/2022
23:56
Hard not to be happy with that outlook and they were very clear no new capital (debt or equity) needed.

We have also been told plenty more contracts to come in the coming weeks or months.

KT_Aim : Early CDT Lung does not work ? That is really your conclusion ? I suggest you look again. It would be fair to say it is slow/hard to commercialise but that is true of all new diagnostics. As you say perhaps are you are just not seeing it.

40 fathoms
28/2/2022
21:17
https://uk.advfn.com/stock-market/london/oncimmune-ONC/share-news/Oncimmune-Holdings-PLC-Contract-signed-with-Verily/87401065

hTTps://verily.com/covid19/

rambutan2
28/2/2022
15:53
Nice recovery - should be strong H2
trotterstrading
28/2/2022
13:39
Terrific insights as always from Adam Hill CEO of Oncimmune

Well worth watching

www.voxmarkets.co.uk/articles/q-a-with-oncimmune-ceo-dr-adam-m-hill-5f97846

brummy_git
27/2/2022
18:05
KT_AIM

you must have been reading the wrong NICE report cos the one that is available speaks highly of EarlyCDT

mg1982
26/2/2022
11:55
Does deflecting attention away from core business work?
Their Early CDT Lung tech doesn't work; recent NICE report pretty damning.

Perhaps it's a hidden gem, i'm just not seeing it

kt_aim
21/2/2022
11:51
Interim results within the next week will hopefully give the market a better understanding of where this business is at.
acuere
21/2/2022
11:11
Today’s fall appears to be collateral damage from SNGs fall today. We saw similar when POLX had their FDA application thrown back. Punters who overexposed themselves on SNG are having to sell other shares to cover their position. A poster elsewhere has confirmed he was a reluctant seller today.
acuere
19/2/2022
04:42
3 comments in 2 months, I love it. Just confirms what a hidden gem that this is.

I am certain that the market does not understand the ImmunoINSIGHTS business and the commercial and medical importance of discovering and validating novel biomarkers, improving disease stratification and understanding disease heterogeneity.

Management are not yet explaining this business, its uniqueness and wider strategic importance in a way that allows a majority of investors to grasp the full extent of the opportunity in front of it. I don't think it would be a bad idea to do it in crayons, I almost mean this literally. A couple of slides in a IR preso that are overly simplified and visual would do wonders in my opinion.

40 fathoms
15/2/2022
08:51
More encouraging contract news today from immunodiagnostics firm Oncimmune

Find out what this means here.

www.linkedin.com/posts/paul-hill-a5994116_onc-onc-onc-activity-6899259635661164544-T6I-

brummy_git
20/1/2022
19:38
Bear or bull?

https://twitter.com/CirlBunt1ng/status/1484234616236130305?s=20

cirlbunting1
24/12/2021
07:42
Adam buying again
philsmi1
21/12/2021
08:37
FY22 is set to be a transformational year for next generation, immunodiagnostics firm Oncimmune

Find out why here.

www.linkedin.com/posts/paul-hill-a5994116_onc-immunoinsights-keytruda-activity-6878975378770190337-tdox

brummy_git
21/12/2021
07:50
Another cracking update!!
trotterstrading
17/12/2021
08:46
Come on Adam get some contracts out
mikeh30
14/12/2021
11:14
Brummy git=Paul Hill ;-)
coalfired
11/12/2021
06:08
Thanks coalfired.

Yes, Oncimmune (starts 28:00) was mentioned positively here on yesterday's Vox "stock picking' video.

www.linkedin.com/posts/paul-hill-a5994116_stocks-to-follow-on-vox-markets-101221-activity-6875044390188982272-YiKA

brummy_git
10/12/2021
13:21
Mentioned on vox markets today. Takeover valuation of £4 talked about
coalfired
Chat Pages: 11  10  9  8  7  6  5  4  3  2  1
Your Recent History
LSE
ONC
Oncimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230131 16:35:31